S&P 500   3,784.06 (+2.87%)
DOW   30,265.79 (+2.63%)
QQQ   282.09 (+3.13%)
AAPL   145.21 (+1.94%)
MSFT   248.77 (+3.34%)
META   141.11 (+1.80%)
GOOGL   101.44 (+2.84%)
AMZN   122.60 (+5.80%)
TSLA   253.15 (+4.43%)
NVDA   131.72 (+5.27%)
NIO   16.80 (+8.46%)
BABA   84.41 (+4.92%)
AMD   68.49 (+3.60%)
T   16.05 (+0.94%)
MU   54.59 (+5.55%)
CGC   3.17 (+8.93%)
F   12.27 (+6.97%)
GE   66.97 (+5.30%)
DIS   101.03 (+4.02%)
AMC   7.38 (+7.27%)
PYPL   92.78 (+6.42%)
PFE   44.37 (+0.52%)
NFLX   239.53 (+0.20%)
S&P 500   3,784.06 (+2.87%)
DOW   30,265.79 (+2.63%)
QQQ   282.09 (+3.13%)
AAPL   145.21 (+1.94%)
MSFT   248.77 (+3.34%)
META   141.11 (+1.80%)
GOOGL   101.44 (+2.84%)
AMZN   122.60 (+5.80%)
TSLA   253.15 (+4.43%)
NVDA   131.72 (+5.27%)
NIO   16.80 (+8.46%)
BABA   84.41 (+4.92%)
AMD   68.49 (+3.60%)
T   16.05 (+0.94%)
MU   54.59 (+5.55%)
CGC   3.17 (+8.93%)
F   12.27 (+6.97%)
GE   66.97 (+5.30%)
DIS   101.03 (+4.02%)
AMC   7.38 (+7.27%)
PYPL   92.78 (+6.42%)
PFE   44.37 (+0.52%)
NFLX   239.53 (+0.20%)
S&P 500   3,784.06 (+2.87%)
DOW   30,265.79 (+2.63%)
QQQ   282.09 (+3.13%)
AAPL   145.21 (+1.94%)
MSFT   248.77 (+3.34%)
META   141.11 (+1.80%)
GOOGL   101.44 (+2.84%)
AMZN   122.60 (+5.80%)
TSLA   253.15 (+4.43%)
NVDA   131.72 (+5.27%)
NIO   16.80 (+8.46%)
BABA   84.41 (+4.92%)
AMD   68.49 (+3.60%)
T   16.05 (+0.94%)
MU   54.59 (+5.55%)
CGC   3.17 (+8.93%)
F   12.27 (+6.97%)
GE   66.97 (+5.30%)
DIS   101.03 (+4.02%)
AMC   7.38 (+7.27%)
PYPL   92.78 (+6.42%)
PFE   44.37 (+0.52%)
NFLX   239.53 (+0.20%)
S&P 500   3,784.06 (+2.87%)
DOW   30,265.79 (+2.63%)
QQQ   282.09 (+3.13%)
AAPL   145.21 (+1.94%)
MSFT   248.77 (+3.34%)
META   141.11 (+1.80%)
GOOGL   101.44 (+2.84%)
AMZN   122.60 (+5.80%)
TSLA   253.15 (+4.43%)
NVDA   131.72 (+5.27%)
NIO   16.80 (+8.46%)
BABA   84.41 (+4.92%)
AMD   68.49 (+3.60%)
T   16.05 (+0.94%)
MU   54.59 (+5.55%)
CGC   3.17 (+8.93%)
F   12.27 (+6.97%)
GE   66.97 (+5.30%)
DIS   101.03 (+4.02%)
AMC   7.38 (+7.27%)
PYPL   92.78 (+6.42%)
PFE   44.37 (+0.52%)
NFLX   239.53 (+0.20%)
NASDAQ:BCRX

BioCryst Pharmaceuticals - BCRX SEC Filings & 10K Form

$13.98
+1.18 (+9.22%)
(As of 10/4/2022 12:03 PM ET)
Add
Compare
Today's Range
$13.22
$14.28
50-Day Range
$10.79
$14.81
52-Week Range
$7.61
$19.99
Volume
183,298 shs
Average Volume
2.31 million shs
Market Capitalization
$2.60 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.86

Recent BioCryst Pharmaceuticals SEC Filings

DateFilerForm TypeView
09/14/2022
3:08 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/02/2022
3:36 PM
BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2022
3:34 PM
BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2022
3:31 PM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2022
3:29 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2022
3:32 PM
BioCryst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/25/2022
6:03 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2022
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2022
3:35 PM
BioCryst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/09/2022
3:53 PM
BioCryst Pharmaceuticals (Issuer)
SANDERS MACHELLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
3:51 PM
BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
3:50 PM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
3:48 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
3:46 PM
BioCryst Pharmaceuticals (Issuer)
McKee Amy E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
3:45 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
3:43 PM
ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
3:41 PM
BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
3:40 PM
BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
3:38 PM
BioCryst Pharmaceuticals (Issuer)
Galson Steven K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
3:36 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2022
3:43 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2022
3:34 PM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
6:00 AM
BioCryst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2022
6:05 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2022
3:31 PM
BioCryst Pharmaceuticals (Filer)
Form DEFA14A
04/25/2022
3:30 PM
BioCryst Pharmaceuticals (Filer)
Form DEF 14A
09/20/2021
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/02/2021
3:30 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2021
3:28 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
6:04 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2021
6:05 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2021
6:34 AM
BioCryst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2021
6:23 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2021
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2021
5:31 PM
BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2021
5:26 PM
BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/28/2021
6:09 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2021
3:39 PM
ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2021
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2021
3:33 PM
BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
3:24 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
3:18 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2021
3:39 PM
BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2021
3:33 PM
BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2021
3:28 PM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2021
3:24 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2021
3:21 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2021
3:16 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2021
3:11 PM
ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2021
3:26 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2021
3:12 PM
ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
8:45 AM
BioCryst Pharmaceuticals (Filer)
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
6:09 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
6:09 AM
BioCryst Pharmaceuticals (Filer)
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2021
9:57 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2021
7:21 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2021
8:36 AM
BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
04/02/2021
4:26 PM
BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2021
1:02 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2021
7:07 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2021
3:41 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2021
3:53 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
3:50 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
3:47 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:07 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2021
8:19 AM
BioCryst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
3:40 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2021
6:05 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2021
3:34 PM
BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
3:25 PM
Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:16 PM
BioCryst Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
02/11/2021
11:54 AM
BioCryst Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/10/2021
3:28 PM
BioCryst Pharmaceuticals (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
02/05/2021
10:42 AM
BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/03/2021
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2021
3:43 PM
BioCryst Pharmaceuticals (Subject)
Sarissa Capital Management LP (Filed by)
Form SC 13G
01/22/2021
6:12 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2020
7:16 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2020
6:03 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2020
6:05 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2020
3:45 PM
BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:41 PM
BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:37 PM
BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:32 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:30 PM
Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:27 PM
BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:23 PM
BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:20 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2020
4:35 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
6:14 AM
BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
12/08/2020
3:12 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:24 PM
BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:23 PM
BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:21 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:19 PM
Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:16 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
8:34 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2020
8:34 AM
BioCryst Pharmaceuticals (Filer)
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2020
3:21 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:19 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:BCRX) was last updated on 10/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.